Insider buying last 90 days
No open-market insider purchases were filed for MKL in the last 90 days.
From Form 4 filings, dated to when each was filed.
Sep 28 close
Markel touched a new 52-week low of 1718.7 USD this week, part of a 19.28% year-to-date decline noted alongside the stock trading 20.82% below its yearly high. Coverage points to improvements in the insurance segment's profitability in Q2 2026, with flat operating revenue year-over-year but a significant increase in net income, even as adjusted operating income declined. The Q2 2026 call also emphasized steady operational improvement in underwriting, combined ratios in the low 90s for four consecutive quarters, expense discipline, and the launch of the Cortex business unit.
Markel closes at $1740.40, up 0.7%, but remains below both its 50-day average of $1839.69 and its 200-day average of $1937.15, with the 50-day below the 200-day. Shares sit near the 52-week low of $1716 and well under the 52-week high of $2207.59, with declines of 3.6% over one month, 11% over three months and 8.6% over the past year. The GekkoIndex reads 69.9, placing the stock in the Accumulation zone, while price sits 7.9% below Gekko Fair Value of $1889.13.
The next earnings date falls on 4 November 2026, 36 days out and outside a typical 20-trading-day hold; the prior report showed EPS of 19.51 against an estimate of 29.94, with a -7.5% reaction. No insider, Congress or unusual options activity appears in the recent windows. Seasonality from this point has averaged +1.8% over the next 20 trading days across 5 years, rising in 2 of them. One tracked analyst holds a rating on the stock, with a consensus target of $1956.33.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Markel scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
Below 50 and 200-day
Close $1740.40 is below the 50-day ($1839.69) and 200-day ($1937.15) averages, and the 50-day is below the 200-day.
See the chart69.9, Accumulation
Reading 69.9 is in the Accumulation zone.
See the GekkoIndex7.9% below
Price is 7.9% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 36 days
Next report Nov 4, 2026, 36 days away — outside a typical 20-trading-day hold.
See earnings+1.8% on average
From this point in the calendar, the next 20 trading days averaged +1.8% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Markel closed at $1,740.40 on Sep 28, 2026, −8.6% over the past year, inside a 52-week range of $1,716.00 to $2,207.59.
Use the left and right arrow keys to read daily values.
Put MKL on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Markel underwrites specialty insurance and reinsurance policies for clients located in North America, Bermuda, Britain, parts of Europe, Canada, Asia Pacific markets, and the Middle East. Its insurance offerings include liability protection, personal coverage, marine and energy policies, workers' compensation, and custom specialty programs, as well as property insurance that guards against fire damage and severe weather events like quakes and windstorms, plus credit, surety, and collateral-related products. On the reinsurance front, Markel handles risk tied to transactions, healthcare claims, and environmental liabilities, alongside treaty-based programs covering credit, political risk, mortgages, and commercial surety.
Apart from underwriting, Markel runs a separate group of companies under its Ventures arm that make things like food-processing and baking machinery, dredging equipment, vehicle transporters, wood flooring, plants, homes, handbags, and building trim, while other units within that arm offer services such as distributing exterior products, renting cranes, fire safety work, business consulting, and retail data analysis. A further part of the company deals in healthcare, leasing, and investment activity, where it manages funds and insurance-related assets, offering tools like catastrophe bonds, weather-linked derivatives, and swap contracts tied to insurance risk, sometimes managing these funds jointly with outside firms.
Markel trades on the NYSE under the ticker MKL.
Markel’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 69.9, in the Accumulation zone, up 3.3 points over five sessions.
Up 3.3 points over five sessions.
Reading for Sep 28, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 34 | +1.1% | +3.6% | ||
| Accumulation (current zone) | 184 | +1.0% | +2.6% | ||
| Neutral | 416 | −0.2% | 0.0% | ||
| Distribution | 37 | −0.6% | −1.4% | ||
| Selling | 1 | Too few readings yet | |||
Average MKL share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Markel trades 7.9% below Gekko Fair Value of $1,889.13, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Markel shares are worth, recalculated every trading day.
$1,889.13
Gekko Fair Value, Sep 26, 2026
7.9% Undervalued
No open-market insider purchases were filed for Markel, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for MKL in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in MKL were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Markel has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds MKL.
Markel reports on Nov 4, 2026 (36 days away), and beat the EPS estimate in 5 of its last 8 reports.
Nov 4, 2026
36 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 29, 2026 | $19.51 est $29.94 | $5.19B est $4.50B | −7.5% |
| Apr 28, 2026 | $23.55 est $26.34 | $2.82B est $3.66B | −7.2% |
| Feb 4, 2026 | $34.45 est $27.62 | $4.22B est $3.64B | +2.8% |
| Oct 29, 2025 | $30.90 est $24.02 | $4.39B est $3.75B | +5.5% |
| Jul 30, 2025 | $25.46 est $24.97 | $4.41B est $4.82B | −0.5% |
| Apr 30, 2025 | $25.72 est $16.77 | $3.33B est $3.92B | +0.3% |
| Feb 5, 2025 | $20.51 est $19.00 | $4.02B est $3.16B | +12.1% |
| Oct 30, 2024 | $17.34 est $21.43 | $4.50B est $3.96B | −1.4% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Markel is $1,956.33, +12.4% from the last close, from 1 firm rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 1 firm.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Jul 31 | Truist Financial | $1,950 | +12.0% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 29, Markel averaged +1.8% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +2.3% | 4 of 5 |
| Next 10 trading days | +2.4% | 4 of 5 |
| Next 15 trading days | +2.3% | 4 of 5 |
| Next 20 trading days | +1.8% | 2 of 5 |
| Next 30 trading days | +5.8% | 4 of 5 |
For scale, MKL’s typical 20-trading-day move in either direction is about 3.6%.
Markel’s market cap is $21.56B, with a P/E ratio of 9.6 and revenue of $16.60B over the last twelve months.
Coverage of Markel this week reads neutral: 0 positive, 3 neutral and 2 negative headlines.
Markel’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| BRK.BBerkshire Hathaway | Accumulation | 3.7% below |
| BRK.ABerkshire Hathaway | Accumulation | 2.8% below |
| CBChubb | Accumulation | 6.2% below |
| TRVTravelers Companies | Accumulation | 1.3% below |
| HIGHartford Insurance | Buying | 11.4% below |
| LLoews | Buying | 15.3% above |
A peer links to its own page where one exists.
Markel’s market cap is $21.56B at the Sep 28, 2026 close of $1,740.40, with 12.39M shares outstanding. The shares trade on a P/E ratio of 9.6.
The consensus analyst 12-month price target for Markel is $1,956.33, +12.4% from the last close. Of the 1 firm that rated the stock in the last 90 days, 0 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Markel is undervalued: the Sep 28, 2026 close of $1,740.40 is 7.9% below Gekko Fair Value of $1,889.13. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Markel is expected to report on Nov 4, 2026 (36 days away). Analysts expect earnings of $27.36 per share on revenue of $3.82B. Markel beat the earnings estimate in 5 of its last 8 reports, moving 4.7% on average across the report.
Markel’s 52-week high is $2,207.59 and its 52-week low is $1,716.00; it closed at $1,740.40 on Sep 28, 2026, −8.6% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and earnings risk), 1 as mixed (seasonality) and 1 as a headwind (trend). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.